Close

Knowledge Bank

Snapshot: Energy-Efficient Systems in Healthcare Facilities

The healthcare industry stands at a very important juncture where the need for operational excellence goes on to intersect with the rising need for environmental sustainability. One of the most pressing concerns in this spectrum is the energy optimization demand within...

Investment Potential of Healthcare in Emerging Markets

It is worth noting that investment in emerging technologies is increasingly being recognized as a very powerful catalyst when it comes to sustainable development and also driving economic growth while at the same time addressing the critical issues of...

AI-Driven Medication Management: Safety and Efficiency

Integrating artificial intelligence (AI) is fundamental to the digital transformation happening in the healthcare business around the world.  The use of artificial intelligence that is, AI-driven medication management is one of its many promising new uses, with the potential...

Gamification in Healthcare Training Enhances Care Outcomes

Medical knowledge, healthcare IT, and patient care systems are all undergoing constant development in the dynamic healthcare industry.  The success of healthcare personnel relies heavily on their continuous professional growth, as they are constantly faced with new knowledge and...

AI in Healthcare Market to Reach $187.7 Billion by 2030

AI in Healthcare Market Revenue worth $187.7 Billion by 2030 Advancements in artificial intelligence (AI) are causing a revolutionary change in the healthcare industry around the world.  The Research Insights did a study that shows the AI in healthcare market...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first AI hospital with 42 AI doctors on staff. Artificial intelligence is still making impressive advances in healthcare.  This ground-breaking facility, known as the Agent Hospital, was created by Tsinghua University's...

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory Agency(MHRA) has approved a low-carbon version of a triple combination pressurised metred dose (pMDI) inhaler designed for adults with moderate-to-severe chronic obstructive pulmonary disease (COPD). The propellant hydrofluoroalkane-134a (HFA-134a), which has...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read